Highlights Akili, Inc.

Equities

AKLI

US00974B1070

Real-time Estimate Cboe BZX Other stock markets 09:13:58 03/06/2024 pm IST			5-day change	1st Jan Change
0.417 ^USD	-0.86%		+0.38%	-13.65%

29/05	PureTech Health's Akili, Virtual Therapeutics Sign Merger Deal to Launch Digital Health Company	MT
29/05	Virtual Therapeutics Corp. entered into an agreement to acquire Akili, Inc. for $35 million.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PureTech Health's Akili, Virtual Therapeutics Sign Merger Deal to Launch Digital Health Company	29/05	MT
Virtual Therapeutics Corp. entered into an agreement to acquire Akili, Inc. for $35 million.	29/05	CI
Akili, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Earnings Flash (AKLI) AKILI Posts Q1 Revenue $383,000, vs. Street Est of $0.8M	15/05	MT
Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product	30/04	CI
Akili, Inc. Announces an Amendment to its Strategic Distribution Agreement with Shionogi & Co., Ltd	30/04	CI
Akili, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/03	CI
Akili, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	01/03	CI
Earnings Flash (AKLI) AKILI Posts Q4 Revenue $749,000, vs. Street Est of $0.78M	01/03	MT
Akili's Japan Partner Submits SDT-001 for Marketing Approval in Japan	26/02	DJ
Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's Endeavorrx®? for Pediatric Adhd Patients in Japan	26/02	CI
Akili, Inc. Receives Authorization from the U.S. Food and Drug Administration	18/12	CI
Earnings Flash (AKLI) AKILI Reports Q3 Revenue $702,000	10/11	MT
Akili, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Akili, Inc. Releases Results from A New Study Examining the Way in Which Adhd Impacting the U.S. Workforce	12/23/12	CI
Akili Releases EndeavorOTC on Android Devices, Expanding Treatment Access for Millions of Adults with Adhd	21/23/21	CI
Akili, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Earnings Flash (AKLI) AKILI Reports Q2 Revenue $114,000	11/23/11	MT
Akili Releases EndeavorOTC Video Game Treatment to Improve Attention in Adults with Adad	07/23/07	CI
Akili, Inc. to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with Adolescents At 2023	31/23/31	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Akili, Inc.

Equities

AKLI

US00974B1070

Highlights

Filters